PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.29%
Revenue growth above 1.5x NXPI's 3.21%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
17.45%
Gross profit growth above 1.5x NXPI's 0.13%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
99.20%
Positive EBIT growth while NXPI is negative. John Neff might see a substantial edge in operational management.
99.20%
Positive operating income growth while NXPI is negative. John Neff might view this as a competitive edge in operations.
269.42%
Positive net income growth while NXPI is negative. John Neff might see a big relative performance advantage.
271.43%
Positive EPS growth while NXPI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
257.14%
Positive diluted EPS growth while NXPI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.54%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
3.44%
Slight or no buyback while NXPI is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
0.54%
Dividend growth above 1.5x NXPI's 0.12%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
34.92%
Similar OCF growth to NXPI's 37.88%. Walter Schloss would assume comparable operations or industry factors.
28.24%
FCF growth under 50% of NXPI's 94.26%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-3.87%
Negative 10Y revenue/share CAGR while NXPI stands at 79.10%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
8.86%
5Y revenue/share CAGR under 50% of NXPI's 77.31%. Michael Burry would suspect a significant competitive gap or product weakness.
-19.76%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
64.67%
10Y OCF/share CAGR at 50-75% of NXPI's 104.58%. Martin Whitman might fear a structural deficiency in operational efficiency.
-17.74%
Negative 5Y OCF/share CAGR while NXPI is at 107.18%. Joel Greenblatt would question the firm’s operational model or cost structure.
4.61%
Positive 3Y OCF/share CAGR while NXPI is negative. John Neff might see a big short-term edge in operational efficiency.
151.10%
Net income/share CAGR above 1.5x NXPI's 36.73% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
147.51%
Below 50% of NXPI's 328.95%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-34.10%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
308.57%
Below 50% of NXPI's 1254.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
72.15%
5Y equity/share CAGR above 1.5x NXPI's 18.89%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
-8.05%
Negative 3Y equity/share growth while NXPI is at 42.98%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
31.93%
Dividend/share CAGR of 31.93% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-1.18%
Negative 5Y dividend/share CAGR while NXPI stands at 169.49%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
5.82%
Below 50% of NXPI's 20.43%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
5.69%
AR growth well above NXPI's 1.04%. Michael Burry fears inflated revenue or higher default risk in the near future.
-0.50%
Inventory is declining while NXPI stands at 0.47%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.09%
Asset growth above 1.5x NXPI's 0.28%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.01%
BV/share growth above 1.5x NXPI's 3.20%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-4.68%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
10.38%
R&D growth drastically higher vs. NXPI's 4.75%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-4.57%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.